Table 3.
Baseline demographics and clinical characteristics of the propensity score matching (PSM) cohort (n=542) and the independent cohort (n=150).
| Characteristics | PSM cohort, n (%) | Independent cohort, n (%) |
|---|---|---|
| Total | 542(100.0) | 150(100.0) |
| Age, years (median/IQR) | 53(43-62) | 61(51-67) |
| Gender | ||
| Male | 346(63.8) | 88 (58.7) |
| Female | 196(36.2) | 62(41.3) |
| ECOG PS score | ||
| 0 | 325(60.0) | 22(14.7) |
| 1-2 | 217(40.0) | 128(85.3) |
| Primary tumor site | ||
| Right | 137(25.3) | 32(21.3) |
| Left | 405(74.7) | 118(78.7) |
| Tumor grade | ||
| G1-2 | 415(76.6) | 112(74.7) |
| G3 | 127(23.4) | 38(25.3) |
| Number of metastatic organs | ||
| 1 | 221(40.8) | 102(68.0) |
| ≥2 | 321(59.2) | 48(32.0) |
| Primary/Metastatic tumor resection | ||
| No | 284(52.4) | 43(28.7) |
| Yes | 258(47.6) | 107(71.3) |
| Chemotherapy | ||
| Chemo alone | 390(72.0) | 104(69.3) |
| Combination | 152(28.0) | 46(30.7) |
| CEA (ng/ml) | ||
| >5 | 340(62.7) | 105(70.0) |
| ≤5 | 202(37.3) | 45(30.0) |
| CA19-9(ng/ml) | ||
| >35 | 235(43.4) | 67(44.7) |
| ≤35 | 307(56.6) | 83(55.3) |
| Cholesterols (mmol/L) | ||
| >6.47 | 45(8.3) | 18(12.0) |
| ≤6.47 | 497(91.7) | 132(88.0) |
| Triglycerides (mmol/L) | ||
| >1.70 | 116(21.4) | 24(16.0) |
| ≤1.70 | 426(78.6) | 126(84.0) |
| HDL-C (mmol/L) | ||
| ≥0.78 | 481(88.7) | 140(93.3) |
| <0.78 | 61(11.3) | 10(6.7) |
| LDL-C (mmol/L) | ||
| >3.40 | 186(34.3) | 53(35.3) |
| ≤3.40 | 356(65.7) | 97(64.7) |
| ApoA-I (ng/L) | ||
| ≥1.05 | 362(66.8) | 49(32.7) |
| <1.05 | 180(33.2) | 101(67.3) |
| ApoB (ng/L) | ||
| >1.15 | 129(23.8) | 40(26.7) |
| ≤1.15 | 413(76.2) | 110(73.3) |
| LDL-C/HDL-C | ||
| ≥2.55 | 297(54.8) | 92(61.3) |
| <2.55 | 245(45.2) | 58(38.7) |
| ApoB/ApoA-I | ||
| ≥0.69 | 351(64.8) | 106(70.7) |
| <0.69 | 191(35.2) | 44(29.3) |
*IQR: interquartile range; ECOG PS score: Eastern Cooperative Oncology Group performance status score; CEA: serum carcinoembryonic antigen; CA19-9: carbohydrate antigen 19-9; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; ApoA-I: apolipoprotein A-I; ApoB: apolipoprotein B; LDL-C/HDL-C: LDL-C to HDL-C ratio; ApoB/ApoA-I: ApoB to ApoA-I ratio.